Latest News
Hispanic/Latinx Community Perspectives on Clinical Trial Participation
Hispanic/Latinx individuals remain critically underrepresented in clinical trials, despite being one of the fastest-growing demographic groups in the United States. This underrepresentation exacerbates healthcare disparities and limits the generalizability of research findings.
Research Articles
Preparing Sites to Be Diverse Capable During Site Selection
With the recent passing...
TOTAL Diversity’s Response to FDA’s Draft Guidance to Industry Regarding Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials
Total Diversity...
A Determination of Variables That Impact Research Site Best Practices: An Analysis of Clinical Trial Site Characteristics as Compared to Scores Using the SCRS Diversity Self-Assessment Tool (DSAT)
By Diana Foster, Ph.D.,...
Identify Opportunities to Improve Diversity Recruitment
Diana Foster, Ph.D.CEO,...
Diversity and Inclusion in Clinical Trials
Diana Foster, Ph.D.CEO,...
The Diversity Site Assessment Tool (DSAT), Reliability and Validity of the Industry Gold Standard for Establishing Investigator Site Ranking
Diana Foster,...